Commentary
Podcast
David Keene, vice president of Digital Therapeutics at atai Life Sciences, discussed the growth and future of digital therapeutics.
This month, we sat down with David Keene, vice president of Digital Therapeutics at atai Life Sciences, to discuss the growth and future of digital therapeutics.
MDMA Rejected: The Story of a Study Participant Entrenched in Ethical Violations
MDMA Rejected: The Story of a Study Participant Entrenched in Ethical Violations
2 Commerce Drive
Cranbury, NJ 08512